← All organizations
Chugai
Also known as: Chugai Pharmaceutical | Chugai Pharmaceutical,Clinical Research Department 2 | Chugai Pharmaceutical Co. | Chugai Pharmaceutical Co., Ltd. Research Dept.1 | Chugai Pharmaceuticals | Chugai Pharma China | Chugai Pharma China Co., Ltd. | Chugai Pharma Europe Ltd. | Chugai Pharma France | Chugai Pharma GmbH | Chugai Pharma Taiwan | Chugai Pharma UK Limited | Chugai Pharma USA | CHUGAI sanofi-aventis | Clinical Research Department 4, Chugai Pharmaceutical Co., Ltd. | clinical-trials@chugai-pharm.co.jp
Highest phase reached
Phase 4
Acquired by Roche on Jan 1, 2014
Timeline
1940s
- Mar 8, 1943
Chugai— Founded
2010s
- Jan 1, 2014
Roche— Acquired By
Drugs by trial phase (106 distinct, 113 trials)
Phase 4 (12 own, 0 via acquisition)
Phase 3 (51 own, 0 via acquisition)
Phase 2 (18 own, 0 via acquisition)
Phase 1 (25 own, 0 via acquisition)
Indications
Studied for
- Adenocarcinoma
- Alzheimer Disease
- Anemia
- Anemia, Aplastic
- Aortic Arch Syndromes
- Arteritis
- Arthritis
- Arthritis, Juvenile
- Arthritis, Rheumatoid
- Atherosclerosis
- Breast Neoplasms
- Carcinoma
- Carcinoma, Hepatocellular
- Colorectal Neoplasms
- Coronary Restenosis
- Dermatitis
- Dermatitis, Atopic
- Eczema
- Fibrosis
- Gallbladder Neoplasms
- Gastroparesis
- Giant Cell Arteritis
- Graft Occlusion, Vascular
- Hemoglobinuria
- Hemoglobinuria, Paroxysmal
- Hemophilia A
- Hepatitis
- Hepatitis A
- Hepatitis C
- Hepatitis C, Chronic
- Hepatitis, Chronic
- Hodgkin Disease
- Hypercalcemia
- Hyperphosphatemia
- Hypoparathyroidism
- Kidney Diseases
- Leukemia
- Leukemia, Lymphocytic, Chronic, B-Cell
- Leukemia, Lymphoid
- Leukemia, Myeloid
- Leukemia, Myeloid, Acute
- Liver Cirrhosis
- Liver Neoplasms
- Lung Neoplasms
- Lymphoma
- Lymphoma, Mantle-Cell
- Lymphoma, Non-Hodgkin
- Lymphoproliferative Disorders
- Multiple Myeloma
- Muscle Spasticity
- Neoplasm Metastasis
- Neoplasms
- Neoplasms, Plasma Cell
- Neuromyelitis Optica
- Osteoporosis
- Osteosarcoma
- Polymyalgia Rheumatica
- Renal Insufficiency, Chronic
- Sarcoma
- Stomach Neoplasms
- Takayasu Arteritis
Recent trials (50)
- NCT07239336OfficialPhase 2Dec 15, 2025
- NCT07239336Lead sponsorPhase 2Dec 15, 2025
- NCT07107490Lead sponsorPhase 1Oct 8, 2025
- NCT07107490OfficialPhase 1Oct 8, 2025
- NCT07030959OfficialPhase 1Jun 5, 2025
- NCT07030959Lead sponsorPhase 1Jun 5, 2025
- NCT06793215CollaboratorPhase 3May 1, 2025
- NCT06819891CollaboratorPhase 3Apr 30, 2025
- NCT06819878CollaboratorPhase 3Mar 10, 2025
- NCT06723106Lead sponsorPhase 1Dec 1, 2024
- NCT06723106OfficialPhase 1Dec 1, 2024
- NCT06497556CollaboratorPhase 3Sep 23, 2024
- NCT06589986CollaboratorPhase 3Sep 17, 2024
- NCT06371417OfficialPhase 1Jun 10, 2024
- NCT06371417Lead sponsorPhase 1Jun 10, 2024
Details
- Founded
- Tokyo, JP Mar 8, 1943
- Last known activity
- Dec 15, 2025